microarray gene expression analysis (Agendia BV)
90
Structured Review
Agendia BV
microarray gene expression analysis
Microarray Gene Expression Analysis, supplied by Agendia BV, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray-based+gene+expression+diagnostic+test/microarray+analysis/pmc09687751-82-6-16
Average 90 stars, based on 1 article reviews
Microarray Gene Expression Analysis, supplied by Agendia BV, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray-based+gene+expression+diagnostic+test/microarray+analysis/pmc09687751-82-6-16
Average 90 stars, based on 1 article reviews
microarray gene expression analysis - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Microarray:Article Title: Association between Obesity, Race or Ethnicity, and Luminal Subtypes of Breast Cancer Article Snippet: .. MammaPrint and BluePrint are based on Article Title: An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer. Article Snippet: To compare results from messenger RNA (mRNA)-based TargetPrint testing with those from immunohistochemistry (IHC) and in situ hybridization (ISH) conducted according to local standard procedures at hospitals worldwide.. Tumor samples were prospectively obtained from 806 patients at 22 hospitals.. The mRNA level of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) was assessed by TargetPrint quantitative gene expression readouts. Article Title: Comparison of molecular subtyping with BluePrint, MammaPrint, and TargetPrint to local clinical subtyping in breast cancer patients. Article Snippet: Purpose.. To compare breast cancer subtyping with the three centrally assessed microarray-based assays BluePrint, MammaPrint, and TargetPrint with locally assessed clinical subtyping using immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH).. Methods. Article Title: Association ofSOD3 promoter DNA methylation with its down-regulation in breast carcinomas Article Snippet: RNAs were extracted by using the QIAGEN RNeasy FFPE kit. .. Article Title: The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER + , HER2 − early breast cancer Article Snippet: .. Article Title: Abstracts and Case Studies From the College of American Pathologists 2012 Annual Meeting (CAP '12) Article Snippet: Abstracts and Case Studies From the College of American Pathologists 2012 Annual Meeting (CAP ’12)s and Case Studies From the College of American Pathologists 2012 Annual Meeting (CAP ’12) Abstract and case study poster sessions will be conducted during the 2012 College of American Pathologists Annual Meeting, which is scheduled for September 9 to 12, 2012.. The meeting will take place at the Manchester Grand Hyatt San Diego, Calif.. The poster sessions will occur in the Elizabeth Ballroom Foyer. Article Title: Dissecting Biological Risk Using Genomic Assays-Implications for Extended Endocrine Therapy and Beyond. Article Snippet: .. MammaPrint, a Gene Expression:Article Title: Association between Obesity, Race or Ethnicity, and Luminal Subtypes of Breast Cancer Article Snippet: .. MammaPrint and BluePrint are based on Article Title: Dissecting Biological Risk Using Genomic Assays-Implications for Extended Endocrine Therapy and Beyond. Article Snippet: .. MammaPrint, a Labeling:Article Title: An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer. Article Snippet: To compare results from messenger RNA (mRNA)-based TargetPrint testing with those from immunohistochemistry (IHC) and in situ hybridization (ISH) conducted according to local standard procedures at hospitals worldwide.. Tumor samples were prospectively obtained from 806 patients at 22 hospitals.. The mRNA level of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) was assessed by TargetPrint quantitative gene expression readouts. Article Title: Comparison of molecular subtyping with BluePrint, MammaPrint, and TargetPrint to local clinical subtyping in breast cancer patients. Article Snippet: Purpose.. To compare breast cancer subtyping with the three centrally assessed microarray-based assays BluePrint, MammaPrint, and TargetPrint with locally assessed clinical subtyping using immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH).. Methods. Article Title: Dissecting Biological Risk Using Genomic Assays-Implications for Extended Endocrine Therapy and Beyond. Article Snippet: .. MammaPrint, a Hybridization:Article Title: An international study comparing conventional versus mRNA level testing (TargetPrint) for ER, PR, and HER2 status of breast cancer. Article Snippet: To compare results from messenger RNA (mRNA)-based TargetPrint testing with those from immunohistochemistry (IHC) and in situ hybridization (ISH) conducted according to local standard procedures at hospitals worldwide.. Tumor samples were prospectively obtained from 806 patients at 22 hospitals.. The mRNA level of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) was assessed by TargetPrint quantitative gene expression readouts. Article Title: Comparison of molecular subtyping with BluePrint, MammaPrint, and TargetPrint to local clinical subtyping in breast cancer patients. Article Snippet: Purpose.. To compare breast cancer subtyping with the three centrally assessed microarray-based assays BluePrint, MammaPrint, and TargetPrint with locally assessed clinical subtyping using immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH).. Methods. Article Title: The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER + , HER2 − early breast cancer Article Snippet: .. Expressing:Article Title: Association ofSOD3 promoter DNA methylation with its down-regulation in breast carcinomas Article Snippet: RNAs were extracted by using the QIAGEN RNeasy FFPE kit. .. Formalin-fixed Paraffin-Embedded:Article Title: Dissecting Biological Risk Using Genomic Assays-Implications for Extended Endocrine Therapy and Beyond. Article Snippet: .. MammaPrint, a Amplification:Article Title: Dissecting Biological Risk Using Genomic Assays-Implications for Extended Endocrine Therapy and Beyond. Article Snippet: .. MammaPrint, a Diagnostic Assay:Article Title: Dissecting Biological Risk Using Genomic Assays-Implications for Extended Endocrine Therapy and Beyond. Article Snippet: .. MammaPrint, a |